Vischer advised Mosanna Therapeutics in connection with its USD 80m Series A funding round. Headquartered in Basel, Switzerland, the clinical-stage biotech company, is working on a nighttime nasal spray to treat obstructive sleep apnea (OSA).
Tags :Vischer
Vischer advised Thommen Group in connection with the acquisition of 100% of the shares in Wiederkehr Recycling, AVO Wiederkehr, SMV Wiederkehr Recycling and the companies Wierec Trading and Wierec Services GmbH (Waltenschwil AG), also belonging to
Vischer advised the Swissphone Group on the sale of certain assets and agreements of the Imasys business to F24 Schweiz. In connection with the deal, private equity firm Rigeto Unternehmerkapital advised the Swissphone Group as
Vischer advised the co-lead and other new investors in Aktiia’s oversubscribed USD 42m Series-B funding-round. Pursuant to the transaction, the blood pressure intelligence platform reached a total funding of USD 100m to date. The
Vischer advised GlycoEra in connection with its financing round. The Swiss biotechnology company, closed a USD 130 million Series B funding. BGPartner advised the lead investor Novo Holdings and new investor LifeArc Ventures on all Swiss
Vischer advised the Matignon Group on its acquisition of 100% of the shares of Meon Clinic and Meon Center, based in Lucerne and Meggen. The company Headquartered in Paris, aesthetic medicine and surgery specialist Matignon Group
Vischer advised MCH Group and Bits & Pretzels in joining forces under the joint venture health.tech events and creating health.tech global summit, an international conference for digital innovations in healthcare. The context Rooted
Walder Wyss and Vischer are amongst the firms involved in Granite Bio’s Series A and Series B financing round. In particular Vischer advised Forbion and Sanofi Ventures on all legal issues related to their
Vischer advised Atanis Biotech, a Swiss biotechnology company, to successful completion of an oversubscribed financing round. The financing round The proceeds from this operation will fund the European and North-American marketing campaigns for Atanis’s “
As of January 2025, Anela Lucic (pictured) has been promoted to partner at Vischer, a firm she has been part of since 2014. The profile Anela Lucic’s area of practice includes advising and representing national and
